Cyient Collaborates with MassMedic to Propel Medtech Innovation

Written by Arushi Sharma

Cyient partners with MassMedic, a leading medtech association, to address critical challenges in the industry.

Cyient Collaborates with MassMedic to Propel Medtech Innovation
Cyient and MassMedic join forces to strengthen the medtech landscape. This collaboration aims to foster innovation, improve product development, and enhance patient outcomes through joint initiatives in the medtech sector.

In a strategic move to bolster the medical technology (medtech) landscape, Cyient has officially joined forces with the Massachusetts Medical Device Industry Council (MassMedic), a prominent regional medtech association based in the United States.

The collaboration is poised to reinforce the medtech community by elevating standards in product development, testing, and compliance with stringent regulatory measures. Anand Parameswaran, President and Business Head of Healthcare & Life Sciences at Cyient, expressed the significance of this partnership, stating, “Joining MassMedic marks a significant milestone in our journey toward becoming a key enabler in the medtech industry. Our goal is to leverage our deep domain knowledge and digital expertise to accelerate innovation, improve patient outcomes, and reduce healthcare costs.”

As part of this collaborative endeavor, Cyient and MassMedic will roll out a series of initiatives designed to tackle critical challenges in the medtech sector. These initiatives will encompass collaborative workshops, thought leadership sessions, and innovation-driven projects. The aim is to foster technological advancements and facilitate knowledge sharing among industry leaders.

Rachel Robinson, Chief Operating Officer of MassMedic, warmly welcomed Cyient’s membership, emphasizing, “Cyient’s engineering excellence and commitment to innovation make them a valuable addition to our association. Together, we look forward to driving significant advancements in the medtech space.”

Anticipated to yield substantial benefits for the medtech community, this partnership is poised to enhance the development and deployment of cutting-edge medical technologies, ultimately contributing to improved health outcomes on a global scale.

Share article